These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3513529

  • 1. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
    Keenan RE, Black PL, Freudenburg JC, Hill JA, Holmburg CE, Reitbrock MJ, Sullivan MJ, Thompson MT, Wright DL.
    Am J Cardiol; 1986 Mar 28; 57(9):38E-42E. PubMed ID: 3513529
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clonidine and guanfacine in hypertension.
    Jain AK, Hiremath A, Michael R, Ryan JR, McMahon FG.
    Clin Pharmacol Ther; 1985 Mar 28; 37(3):271-6. PubMed ID: 3882307
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
    Rosenthal JH.
    Am J Cardiol; 1986 Mar 28; 57(9):22E-26E. PubMed ID: 3513526
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S.
    Clin Ther; 1985 Mar 28; 7(2):199-204. PubMed ID: 3886142
    [Abstract] [Full Text] [Related]

  • 10. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL, Strocchi E, Ambrosioni E, Magnani B.
    Int J Clin Pharmacol Res; 1983 Mar 28; 3(1):35-9. PubMed ID: 6384071
    [Abstract] [Full Text] [Related]

  • 11. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG, Bloxham CA, Walker JM.
    Pharmatherapeutica; 1981 Mar 28; 2(8):513-6. PubMed ID: 7019931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC, Fiske K, Lyne A.
    Clin Ther; 2007 Sep 28; 29(9):1967-79. PubMed ID: 18035196
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I, Kállay K.
    Br J Clin Pharmacol; 1980 Sep 28; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Guanfacine as monotherapy for systemic hypertension.
    Fillingim JM, Blackshear JL, Strauss A, Strauss M.
    Am J Cardiol; 1986 Mar 28; 57(9):50E-54E. PubMed ID: 3513531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term antihypertensive therapy with guanfacine.
    Szám I, Holló J.
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug 28; 20(8):388-92. PubMed ID: 6749702
    [Abstract] [Full Text] [Related]

  • 20. Effect of guanfacine on ambulatory blood pressure and its variability in elderly patients with essential hypertension.
    Dupont AG, Vanderniepen P, Six RO.
    Br J Clin Pharmacol; 1987 Apr 28; 23(4):397-401. PubMed ID: 3555578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.